Pharma companies stockpile drugs in US ahead of expected Trump tariffs, while execs warn of R&D cuts and manufacturing ...

Good company, bad environment. That’s the takeaway from RBC Dominion Securities analyst Paul Treiber’s latest report on ...

In a report released today, Biraj Borkhataria from RBC Capital maintained a Buy rating on ENI S.p.A. (0N9S – Research Report), with a price ...

According to the brokerage, the rate of upward earnings per share (EPS) estimate revisions for the S&P 500 has dropped to 30% on a weekly basis. The four-week average now stands at 36%, down from the ...

In a report released yesterday, Jon Arfstrom from RBC Capital maintained a Hold rating on Zions Bancorporation National Association (ZION – ...